Effective as of January 10, 2024, Dr. Neil Campbell resigned as Chief Executive Officer of Onconetix, Inc. Dr. Campbell?s resignation is not the result of any disagreement with the Company relating to the Company?s operations, policies or practices. On January 12, 2024, the Board appointed Dr. Ralph Schiess, the Company?s Chief Science Officer, to serve as the Company?s Interim Chief Executive Officer. As Interim Chief Executive Officer, Dr. Schiess shall have general supervision and direction of the business and affairs of the Company.